HABA Laboratories,Inc.

TSE:4925.T

1995 (JPY) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 12,324.2112,038.05212,908.86114,307.70918,369.6419,253.55717,885.68816,135.56714,811.07813,181.17813,786.97113,233.76713,578.54411,809.97911,318.01511,182.79811,042.84
Cost of Revenue 4,298.1473,869.534,114.0514,107.7594,705.4354,740.8974,546.7584,023.0023,628.2343,205.1023,309.5773,404.8213,430.1972,210.882,278.512,425.5852,405.461
Gross Profit 8,026.0638,168.5228,794.8110,199.9513,664.20514,512.6613,338.9312,112.56511,182.8449,976.07610,477.3949,828.94610,148.3479,599.0999,039.5058,757.2138,637.379
Gross Profit Ratio 0.6510.6790.6810.7130.7440.7540.7460.7510.7550.7570.760.7430.7470.8130.7990.7830.782
Reseach & Development Expenses 125.108176.4152.565148.949150.214170.552213.501218.214224.68624726322400000
General & Administrative Expenses 4,297.7244,338.294,332.9894,438.2525,322.8464,918.8084,889.2514,600.3494,362.564,2804,3284,43500000
Selling & Marketing Expenses 3,7913,9124,1644,8775,7285,8795,4435,2164,5974,9634,3824,38100000
SG&A 8,088.7248,250.298,496.9899,315.25211,050.84610,797.80810,332.2519,816.3498,959.569,2438,7108,81600000
Other Expenses 4.56133.42131.97530.584-15.53212.3227.4214.71651.40314.5314.9143.33848.55441.49561.17559.36732.613
Operating Expenses 8,213.8328,778.1659,111.549,972.97511,666.33111,417.61710,938.67210,342.9229,657.5269,693.2229,223.3059,401.1389,112.7738,938.8758,139.447,875.5057,955.599
Operating Income -187.769-609.642-316.73226.9741,997.8733,095.0432,400.2571,769.6421,525.317282.8531,254.088427.8071,035.573660.222900.064881.707681.779
Operating Income Ratio -0.015-0.051-0.0250.0160.1090.1610.1340.110.1030.0210.0910.0320.0760.0560.080.0790.062
Total Other Income Expenses Net -1,655.54360.97849.77556.953-70.246-21.604-19.849-24.693141.479-43.314387.979-257.555-124.426-210.761-257.167-79.294-72.518
Income Before Tax -1,843.312-548.664-266.955283.9271,927.6273,073.4392,380.4081,744.9491,666.796239.5391,642.067170.252911.147449.461642.897802.413609.261
Income Before Tax Ratio -0.15-0.046-0.0210.020.1050.160.1330.1080.1130.0180.1190.0130.0670.0380.0570.0720.055
Income Tax Expense 275.315159.2012.07567.508614.151984.961782.56531.338684.393194.704725.713160.2373.281415.244425.974356.631252.868
Net Income -2,118.627-707.865-269.03216.4191,313.4752,088.4781,597.8471,213.611982.40344.834916.35410.052537.86522.127266.498393.361299.831
Net Income Ratio -0.172-0.059-0.0210.0150.0720.1080.0890.0750.0660.0030.0660.0010.040.0020.0240.0350.027
EPS -560.26-187.19-71.1457.12339.24530.93405.99308.36249.6411.19232.862.54136.725.6267.7499.9991.02
EPS Diluted -560.26-187.19-71.1457.12339.24530.93405.99308.36249.6411.19232.862.54136.725.6267.7499.9991.02
EBITDA 331.501-16.911422.668926.9072,612.783,724.5253,024.6182,312.4272,193.366881.8591,903.3041,094.1761,716.9481,159.9011,412.2151,406.8191,162.148
EBITDA Ratio 0.027-0.0010.0330.0650.1420.1930.1690.1430.1480.0670.1380.0830.1260.0980.1250.1260.105